Abstract
The identification of genetic factors that control the pathogenetic pathways of autoimmune neuroinflammation and degeneration may provide targets for new therapeutic strategies in human diseases, such as multiple sclerosis. This is not easily accomplished as significant heterogeneity exists and such genetic dissection may more easily be performed using inbred rodent strains, where the genetic heterogeneity is avoided and variation in the environmental influences is minimized. Chronic relapsing experimental autoimmune encephalomyelitis (EAE) exhibits some histopathological features typical of multiple sclerosis and provides a tool to systemically identify genetic influences controlling susceptibility through genome scanning and selective breeding of congenic animals harbouring disease-related loci. As with MS, susceptibility is controlled by expression of certain major histocompatibility complex allotypes, which in EAE is in response to induction with certain myelin antigens. Both are complex polygenic diseases where disease traits are controlled by a number of polymorphic genes which individually exhibiting modest effect on disease course. A number of as yet largely unknown genes, cluster in certain regions that are sometimes shared between different strain combinations and are also shared by other inflammatory diseases, as they are uncovered the biology understood they may open avenues to treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abdul-Majid K-B, Jirholt J, Stadelmann C, Stefferl A, Kjellen P, Wallstrom R, Holmdahl R, Lassmann H, Olsson T, Harris RA. q Screening of several H-2 congenic mouse strains identified H-2 mice as highly susceptible to MOG-induced EAE with minimal adjuvant requirement. Journal of Neuroimmunology 2000; 111: 23–33
Akesson E, Oturai A, Berg J, Fredrikson S, Andersen O, Harbo HF, Laaksonen M, Myhr KM, Nyland HI, Ryder LP, Sandberg-Wollheim M, Sorensen PS, Spurkland A, Svejgaard A, Holmans P, Compston A, Hillert J, Sawcer S. A genome-wide screen for linkage in Nordic sib-pairs with multiple sclerosis. Genes Immun. 2002;3:279–85.
Amor, S., Groome, N., Linington, G, Morris, M.M., Dornmair, K., Gardinier, M.V., Matthieu, J.M., Baker, D. Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H J. Immunol. 1994; 153: 4349–4356.
Baker D, O’Neill JK, Gschmeissner SE, Wilcox CE, Butter C, Turk JL. Induction of chronic relapsing experimental allergic encephalomyelitis in Biozzi mice. J Neuroimmunol. 1990;28:261–70.
Baker D, Rosenwasser OA, O’Neill JK, Turk JL. Genetic analysis of experimental allergic encephalomyelitis in mice. J Immunol. 1995; 155:4046–51.
Ban M, Stewart GJ, Bennetts BH, Heard R, Simmons R, Maranian M, Compston A, Sawcer SJ. A genome screen for linkage in Australian sibling-pairs with multiple sclerosis. Genes Immun. 2002; 3:464–9.
Barcellos LF, Thomson G, Carrington M, Schafer J, Begovich AB, Lin P, Xu XH, Min BQ, Marti D, Klitz W: Chromosome 19 single-locus and multilocus haplotype associations with multiple sclerosis. Evidence of a new susceptibility locus in Caucasian and Chinese patients. JAMA 1997, 278:1256–1261
Barry R, Bolton C, Glynn P, Groome N. Myelin basic protein peptides in urine. Ann Neurol. 1992; 31:345–8.
Becanovic K, Backdahl L, Wallstrom E, Aboul-Enein F, Lassmann H, Olsson T, Lorentzen JC. Paradoxical effects of srthritis-regulating chromosome 4 rgions on myelin oligodendrocyte glycoprotein induced. Eur J Immunol. 2003a;33:19076–16.
Becanovic K, Wallstrom E, Kornek B, Glaser A, Broman KW, Dahlman I, Olofsson P, Holmdahl R, Luthman H, Lassmann H, Olsson T. New loci regulating rat myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol. 2003b;170:1062–9.
Bergsteinsdottir K, Yang HT, Pettersson U, Holmdahl R. Evidence for common autoimmune disease genes controlling onset, severity, and chronicity based on experimental models for multiple sclerosis and rheumatoid arthritis. J Immunol. 2000: 164:1564–8.
Bjartmar C, Wujek JR, Trapp BD. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease. J Neurol Sci 2003;206:165–71.
Blankenhorn E P, Butterfield RJ, Rigby R, Cort L, Giambrone D, McDermott R, McEntee K, Solowski N, Meeker ND, Zachary JF, Doerge RW, Teuscher C: Genetic analysis of the influence of pertussis toxin on EAE susceptibility: an environmental agent can override genetic checkpoints. J Immunol 2000, 164:3420–3425
Bebo BF Jr, Zelinka-Vincent E, Adamus G, Amundson D, Vandenbark AA, Offner H: Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 1998, 84:122–130
Bebo BF Jr, Schuster JC, Vandenbark AA, Offner H: Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. J Immunol 1999, 162:35–40
Bettelli E, Pagany M, Weiner HL, Linington C, Sobel RA, Kuchroo VK. oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis. J Exp Med. 2003; 197:1073–81.
Brabb T, Goldrath AW, von Dassow P, Paez A, Liggitt HD, Goverman J Triggers of autoimmune disease in a murine TCR-transgenic model for multiple sclerosis. J Immunol. 1997;159:497–507.
Brahic M, Bureau JF. Genetics of susceptibility to Theiler’s virus infection. Bioessays. 1998; 20:627–33.
Broadley S, Sawcer S, D’Alfonso S, Hensiek A, Coraddu F, Gray J, Roxburgh R, Clayton D, Buttinelli C, Quattrone A, Trojano M, Massacesi L, Compston A. A genome screen for multiple sclerosis in Italian families. Genes Immun. 2001; 2:205–10
Brocke S, Gijbels K, Steinman L: Experimental autoimmune encephalomyelitis in the mouse. Autoimmune Disease Models, a Guidebook. Edited by IR Cohen, A Miller. New York, Academic Press, 1994, pp1–14
Brok HP, Bauer J, Jonker M, Blezer E, Amor S, Bontrop RE, Laman JD, ’t Hart BA. Non-human primate models of multiple sclerosis. Immunol Rev. 2001; 183:173–85.
Butterfield RJ, Sudweeks JD, Blankenhorn EP, Korngold R, Marini JC, Todd JA, Roper RJ, Teuscher C: New genetic loci that control susceptibility and symptoms of experimental allergic encephalomyelitis in inbred mice. J Immunol 1998, 161:1860–1867
Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Sudweeks J, Rose J, Teuscher C: Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/ nonrelapsing EAE are immunogenetically distinct. J Immunol 1999, 162:3096–3102
Butterfield RJ, Blankenhorn EP, Roper RJ, Zachary JF, Doerge RW, Teuscher C. Identification of genetic loci controlling the characteristics and severity of brain and spinal cord lesions in experimental allergic encephalomyelitis. Am. J. Pathol. 2000; 157:637–645.
Bruno R, Sabater L, Sospedra M, Ferrer-Francesch X, Escudero D, Martinez-Caceres E, Pujol-Borrell R. Multiple sclerosis candidate autoantigens except myelin oligodendrocyte glycoprotein are transcribed in human thymus. Eur J Immunol. 2002; 32:2737–47.
Chataway, J., Feakes, R., Coraddu, F., Gray, J., Deans, J., Fraser, M., Robertson, N., Broadley, S., Jones, H., Clayton, D., Goodfellow, P., Sawcer, S., Compston, A., The genetics of multiple sclerosis: principles, background and updated results of the United Kingdom systematic genome screen. Brain, 1998; 121, 1869–1887.
Compston A, Coles A. Multiple sclerosis. Lancet 2002; 359: 1221–1231.
Compston A, Sawcer S. Genetic analysis of multiple sclerosis. Curr Neurol Neurosci Rep. 2002;2:259–66.
Confavreux C, Vukusic S, Moreau T, Adeleine P. Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430–38.
Coraddu F, Sawcer S, Feakes R, Chataway J, Broadley S, Jones HB, Clayton D, Gray J, Smith S, Taylor C, Goodfellow PN, Compston A. HLA typing in the United Kingdom multiple sclerosis genome screen. Neurogenetics. 1998; 2:24–33.
Coraddu F, Sawcer S, D’Alfonso S, Lai M, Hensiek A, Solla E, Broadley S, Mancosu C, Pugliatti M, Marrosu MG, Compston A. A genome screen for multiple sclerosis in Sardinian multiplex families. Eur J Hum Genet. 2001;9:621–6.
Croxford JL, O’Neill JK, Baker D. Polygenic control of experimental allergic encephalomyelitis in Biozzi ABH and BALB/c mice. J Neuroimmunol. 1997; 74:205–11.
Dalai M, Kim S, Voskuhl RR: Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. J Immunol 1997,159:3–6
Dahlman I, Lorentzen JC, de Graaf KL, Stefferl A, Linington C, Luthman H, Olsson T. Quantitative trait loci disposing for both experimental arthritis and encephalomyelitis in the DA rat; impact on severity of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis and antibody isotype pattern. Eur J Immunol. 1998; 28:2188–96.
Dahlman I, Jacobsson L, Glaser A, Lorentzen JC, Andersson M, Luthman H, Olsson T. Genome-wide linkage analysis of chronic relapsing experimental autoimmune encephalomyelitis in the rat identifies a major susceptibility locus on chromosome 9. J Immunol. 1999a;162:2581–8
Dahlman I, Wallstrom E, Weissert R, Storch M, Kornek B, Jacobsson L, Linington C, Luthman H, Lassmann H, Olsson T. Linkage analysis of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis in the rat identifies a locus controlling demyelination on chromosome 18. Hum Mol Genet. 1999b;8:2183–90.
Duquette P, Pleines J, Girard M, Charest L, Senecal-Quevillon M, Masse C: The increased susceptibility of women to multiple sclerosis. Can J Neurol Sci 1992, 19:466–471
Ebers GC, Sadovnick AD, Risch NJ: A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 1995, 377:150–151
Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, Anderson C, Armstrong H, Cousin K, Bell RB, Hader W, Paty DW, Hashimoto S, Oger J, Duquette P, Warren S, Gray T, O’Connor P, Nath A, Auty A, Metz L, Francis G, Paulseth JE, Murray TJ, Pryse-Phillips W, Risch N: A full genome search in multiple sclerosis. Nat Genet 1996, 13:472–476.
Encinas, JA, Lees MB, Sobel RA, Symonowics C, Greer JM, Shovlin CL, Weiner HL, Seidman CE, Seidman JG, Kuchroo VJ. Genetic analysis of susceptibility to experimental autoimmune encephalomyelitis in a cross between SJL/L and B10.S mice. J. Immunol. 1996; 157:2186.
Encinas JA, Wicker LS, Peterson LB, Mukasa A, Teuscher C, Sobel R, Weiner HL, Seidman CE, Seidman JG, Kuchroo VK: QTL influencing autoimmune diabetes and encephalomyelitis map to a 0.15 cM region containing I12. Nat Genet 1999,21:158–160.
Encinas JA, Kuchroo VK. Mapping and identification of autoimmunity genes Curr Opin Immunol. 2000;12:691–7.
Encinas, JA, Lees MB, Sobel RA, Symonowics C, Weiner HL, Seidman CE, Seidman JG, Kuchroo VJ. Identification of genetic loci associated with paralysis, inflammation and weight loss in mouse experimental autoimmune encephalomyelitis. Int. Immunol. 2001; 13:257–64
Feakes R, Sawcer S, Smillie B, Chataway J, Broadley S, Compston A. No evidence for the involvement of interleukin 2 or the immunoglobulin heavy chain gene cluster in determining genetic susceptibility to multiple sclerosis. J Neurol Neurosurg Psychiatry. 2000; 68:679.
Fritz, RB, Skeen MJ, Chou CH, Garcia M, Egorov IK. Major histocompatibility complex-linked control of the murine immune response to myelin basic protein. J. Immunol. 1985; 134:2328–2332.
Furlan R, Brambilla E, Sanvito F, Roccatagliata L, Olivieri S, Bergami A, Pluchino S, Uccelli A, Comi G, Martino G. Vaccination with amyloid-beta peptide induces autoimmune encephalomyelitis in C57/BL6 mice. Brain. 2003;126:285–91.
Gao JF, Call SB, Fillmore PD, Watanabe T, Meeker ND, Teuscher C. Analysis of the role of Bphs/Hrhl in the genetic control of responsiveness to pertussis toxin. Infect Immun. 2003;71:1281–7.
Goedde R, Sawcer S, Boehringer S, Miterski B, Sindern E, Haupts M, Schimrigk S, Compston A, Epplen JT. A genome screen for linkage disequilibrium in HLA-DRB1*15-positive Germans with multiple sclerosis based on 4666 microsatellite markers. Hum Genet. 2002; 111:270–7.
Goverman J, Woods A, Larson L, Weiner LP, Hood L, Zaller DM Transgenic mice that express a myelin basic protein-specific T cell receptor develop spontaneous autoimmunity. Cell. 1993;72:551–60.
Haines JL, Ter Minassian M, Bazyk A, Gusella JF, Kim DJ, Terwedow H, Pericak-Vance MA, Rimmler JB, Haynes CS, Roses AD, Lee A, Shaner B, Menold M, Seboun E, Fitoussi RP, Gartioux C, Reyes C, Ribierre F, Gyapay G, Weissenbach J, Hauser SL, Goodkin DE, Lincoln R, Usuku K, Oksenberg JR: A complete genomic screen for multiple sclerosis underscores a role for the major histocompatibility complex. The Multiple Sclerosis Genetics Group. Nat Genet 1996, 13:469–471
Hensiek AE, Sawcer SJ, Feakes R, Deans J, Mander A, Akesson E, Roxburgh R, Coraddu F, Smith S, Compston DA. HLA-DR 15 is associated with female sex and younger age at diagnosis in multiple sclerosis. J Neurol Neurosurg Psychiatry. 2002; 72:184–7.
Hogancamp WE, Rodriguez M, Weinshenker BG: The epidemiology of multiple sclerosis. Mayo Clin Proc 1997, 72:871–878
Homo-Delarche F, Fitzpatrick F, Christeff N, Nunez EA, Bach JF, Dardenne M: Sex steroids, glucocorticoids, stress and autoimmunity. J Steroid Biochem Mol Biol 1991, 40:619–637
Ichikawa M, Koh CS, Inaba Y, Seki C, Inoue A, Itoh M, Ishihara Y, Bernard CC, Komiyama A. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice. Cell Immunol. 1999; 191:97–104.
Jansson L, Holmdahl R. Estrogen-mediated immunosuppression in autoimmune diseases. Inflamm. res. 1998, 47:290–301
Jirholt, J., A.-K. Lindqvist, J. Karlsson, A. Andersson, and R. Holmdahl. Identification of susceptibility genes for experimental autoimmune encephalomyelitis that overcome the effect of protective alleles at the eae2 locus. Int. Immunol. 2002;14:79–85
Karlsson J, Zhao, Lonskaya I, Neptin M, Holmdahl R, Andersson A. Novel quantitative trait loci controlling development of experimental autoimmune encephalomyelitis and proportion of lymphocyte subpopulations. J. Immunol 2003 170:1019–1026
Kira J, Kanai T, Nishimura Y, Yamasaki K, Matsushita S, Kawano Y, Hasuo K, Tobimatsu S, Kobayashi T: Western versus Asian types of multiple sclerosis: immunogenetically and clinically distinct disorders. Ann Neurol 1996, 40:569–574
Kjellén P, Jansson, Vestberg M, A Andersson, Mattsson R, Holmdahl. The H2-Ab gene influences the severity of experimental allergic encephalomyelitis induced by proteolipoprotein 103–116 J. Neuroimmunol. 2001; 120:25–33
Kojima K, Berger T, Lassmann H, Hinze-Selch D, Zhang Y, Gehrmann J, Reske K, Wekerle H, Linington C. Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J Exp Med. 1994; 180:817–29.
Kuokkanen S, Gschwend M, Rioux JD, Daly MJ, Terwilliger JD, Tienari PJ, Wikstrom J, Palo J, Stein LD, Hudson TJ, Lander ES, Peltonen L: Genomewide scan of multiple sclerosis in Finnish multiplex families. Am J Hum Genet 1997, 61:1379–1387
Kuokkanen S, Sundvall M, Terwilliger JD, Tienari PJ, Wikstrom J, Holmdahl R, Pettersson U, Peltonen L. A putative vulnerability locus to multiple sclerosis maps to 5pl4-pl2 in a region syntenic to the murine locus Eae2. Nat Genet 1996, 13:477–480
Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB. T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol. 2002;20:101–23.
Larsen F, Oturai A, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Harbo HF, Sawcer S, Fugger L, Sorensen PS, Svejgaard A. Linkage analysis of a candidate region in Scandinavian sib pairs with multiple sclerosis reveals linkage to chromosome 17q. Genes Immun. 2000; 1:456–9.
Levine S, Sowinski R. Experimental allergic encephalomyelitis in inbred and outbred mice. J Immunol. 1973; 110:139–43.
Li Y, Li H, Martin R, Mariuzza RA. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J Mol Biol. 2000;304:177–88.
Lublin FD, Reingold SC: Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 1996, 46:907–911
Lucchinetti CF, Bruck W, Rodriguez M, Lassmann H: Distinct patterns of multiple sclerosis pathology indicates heterogeneity on pathogenesis. Brain Pathol 1996, 6:259–274
Lyons PA, Armitage N, Argentina F, Denny P, Hill NJ, Lord CJ, Wilusz MB, Peterson LB, Wicker LS, Todd JA. Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. Genome Res. 2000;10:446–53.
Lyons PA, Armitage N, Lord CJ, Phillips MS, Todd JA, Peterson LB, Wicker LS. Mapping by genetic interaction: high-resolution congenic mapping of the type 1 diabetes loci Iddl0 and Iddl8 in the NOD mouse. Diabetes. 2001; 50:2633–7.
Ma RZ, Gao J, Meeker ND, Fillmore PD, Tung KS, Watanabe T, Zachary JF, Offner H, Blankenhorn EP, Teuscher C. Identification of Bphs, an autoimmune disease locus, as histamine receptor H1. Science. 2002;297:620–3.
Madsen LS, Andersson EC, Jansson L, krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet. 1999;23:343–7.
Marrosu MG, Murru MR, Costa G, Cucca F, Sotgiu S, Rosati G, Muntoni F. Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and-DR4 alleles. Am J Hum Genet. 1997;61:454–7.
Mendel I, Kerlero de Rosbo N, Ben-Nun A. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic cells. Eur. J. Immunol. 1995; 25: 1951–1959.
Mendel I, Gur H, Kerlero de Rosbo N, Ben-Nun A. Experimental autoimmune encephalomyelitis induced in B6.C-H-2bml2 mice by myelin oligodendrocyte glycoprotein: effect of MHC class II mutation on immunodominant epitope selection and fine epitope specificity of encephalitogenic T cells. J Neuroimmunol. 1999;96:9–20.
Merriman TR, Cordell HJ, Eaves IA, Danoy PA, Coraddu F, Barber R, Cucca F, Broadley S, Sawcer S, Compston A, Wordsworth P, Shatford J, Laval S, Jirholt J, Holmdahl R, Theofilopoulos AN, Kono DH, Tuomilehto J, Tuomilehto-Wolf E, Buzzetti R, Marrosu MG, Undlien DE, Ronningen KS, Ionesco-Tirgoviste C, Shield JP, Pociot F, Nerup J, Jacob CO, Polychronakos C, Bain SC, Todd JA. Suggestive evidence for association of human chromosome 18ql2-q21 and its orthologue on rat and mouse chromosome 18 with several autoimmune diseases. Diabetes. 2001;50:184–94.
Morris-Downes MM, McCormack K, Baker D, Sivaprasad D, Natkunarajah J, Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J Neuroimmunol. 2002; 122:20–33.
Olerup O, Hillert J, Fredrikson S, Olsson T, Kam-Hansen S, Moller E, Carlsson B, Wallin J: Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989, 86:7113–7117
Olsson T, Dahlman I, Wallström E, Weissert R, Piehl F. Genetics of rat Neuroinflammation. J. Neuroimmunol 2000; 107:191–200
O’Neill JK, Baker D, Davison AN, Allen SJ, Butter C, Waldmann H, Turk JL. Control of immune-mediated disease of the central nervous system with monoclonal (CD4-specific) antibodies. J Neuroimmunol. 1993; 45:1–14.
Oturai A, Larsen F, Ryder LP, Madsen HO, Hillert J, Fredrikson S, Sandberg-Wollheim M, Laaksonen M, Koch-Henriksen N, Sawcer S, Fugger L, Sorensen PS, Svejgaard A. Linkage and association analysis of susceptibility regions on chromosomes 5 and 6 in 106 Scandinavian sibling pair families with multiple sclerosis. Ann Neurol. 1999; 46:612–6.
Pagany M, Jagodic M, Bourquin C, Olsson T, Linington C. Genetic variation in myelin oligodendrocyte glycoprotein expression and susceptibility to experimental autoimmune encephalomyelitis. J Neuroimmunol. 2003;139:1–8.
Pihlaja H, Rantamaki T, Wikstrom J, Sumelahti ML, Laaksonen M, Ilonen J, Ruutiainen J, Pirttila T, Elovaara I, Reunanen M, Kuokkanen S, Peltonen L, Koivisto K, Tienari PJ. Linkage disequilibrium between the MBP tetranucleotide repeat and multiple sclerosis is restricted to a geographically defined subpopulation in Finland. Genes Immun. 2003; 4:138–46.
Podolin PL, Denny P, Lord CJ, Hill NJ, Todd JA, Peterson LB, Wicker LS, Lyons PA. Congenic mapping of the insulin-dependent diabetes (Idd) gene, Iddl0, localizes two genes mediating the Iddl0 effect and eliminates the candidate Fcgrl. J Immunol. 1997;159:1835–43.
Podolin PL, Wilusz MB, Cubbon RM, Pajvani U, Lord CJ, Todd JA, Peterson LB, Wicker LS, Lyons PA. Differential glycosylation of interleukin 2, the molecular basis for the NOD Idd3 type 1 diabetes gene? Cytokine. 2000; 12:477–82.
Prins JB, Todd JA, Rodrigues NR, Ghosh S, Hogarth PM, Wicker LS, Gaffney E, Podolin PL, Fischer PA, Sirotina A, et al. Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. Science. 1993;260:695–8.
Raine CS, Barnett LB, Brown A, Behar T, McFarlin DE: Neuropathology of experimental allergic encephalomyelitis in inbred strains of mice. Lab Invest 1980, 43:150–157
Reboul J, Mertens C, Levillayer F, Eichenbaum-Voline S, Vilkoren T, Cournu I, Babron MC, Lyon-Caen O, Clerget-Darpoux F, Edan G, Clanet M, Brahic M, Bureau JF, Fontaine B, Liblau R. Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics Group. J Neuroimmunol 2000, 102:107–112.
Roth MP, Viratelle C, Dolbois L, Delverdier M, Borot N, Pelletier L, Druet P, Clanet M, Coppin H. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10. J Immunol. 1999;162:1917–22.
Sadlack B, Lohler J, Schorle H, Klebb G, Haber H, Sickel E, Noelle RJ, Horak I. Generalized autoimmune disease in interleukin-2-deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells. Eur J Immunol. 1995;25:3053–9.
Sawcer S, Jones HB, Feakes R, Gray J, Smaldon N, Chataway J, Robertson N, Clayton D, Goodfellow PN, Compston A: A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nat Genet 1996, 13:464–468
Sawcer S, Maranian M, Setakis E, Curwen V, Akesson E, Hensiek A, Coraddu F, Roxburgh R, Sawcer D, Gray J, Deans J, Goodfellow PN, Walker N, Clayton D, Compston A. A whole genome screen for linkage disequilibrium in multiple sclerosis confirms disease associations with regions previously linked to susceptibility. Brain. 2002; 125:1337–47.
Seboun E, Oksenberg JR, Rombos A, Usuku K, Goodkin DE, Lincoln RR, Wong M, Pham-Dinh D, Boesplug-Tanguy O, Carsique R, Fitoussi R, Gartioux C, Reyes C, Ribierre F, Faure S, Fizames C, Gyapay G, Weissenbach J, Dautigny A, Rimmler JB, Garcia ME, Pericak-Vance MA, Haines JL, Hauser SL. Linkage analysis of candidate myelin genes in familial multiple sclerosis. Neurogenetics. 1999; 2:155–62.
Slavin A, Ewing C, Liu J, Ichikawa M, Slavin J, Bernard CC. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein. Autoimmunity. 1998;28:109–20.
Sudweeks JD, Todd JA, Blankenhorn EP, Wardell BB, Woodward SR, Meeker ND, Estes SS, Teuscher C: Locus controlling Bordetella pertussis-induced histamine sensitization (Bphs), an autoimmune disease-susceptibility gene, maps distal to T-cell receptor beta-chain gene on mouse chromosome 6. Proc Natl Acad Sci USA 1993, 90:3700–3704
Sun D, Whitaker JN, Huang Z, Liu D, Coleclough C, Wekerle H, Raine CS. Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J Immunol. 2001; 166:7579–87
Sundvall, M, Jirholt J, Yang HT, Jansson L, Engstrom A, Pettersson U, Holmdahl R. Identification of murine loci associated with susceptibility to chronic experimental autoimmune encephalomyelitis. Nat. Genet. 1995, 10:313–317.
Teuscher C, Butterfield RJ, Ma RZ, Zachary JF, Doerge RW, Blankenhorn EP: Sequence polymorphisms in the chemokines Scyal(TCA-3), Scya2 (monocyte chemoattractant protein (MCP)-l), and Scyal2 (MCP-5) are candidates for eae7, a locus controlling susceptibility to monophasic remitting/nonrelapsing experimental allergic encephalomyelitis. J Immunol 1999, 163:2262–2266
t’Hart B, Amor S. The use of animal models to investigate the pathogenesis of neuroinflammatory disorders of the central nervous sysyem. Curr Opin Neurol. 2003;16:375–384
Thompson AJ, Polman CH, Miller DH, McDonald WI, Brochet B, Filippi MMX, De Sa J: Primary progressive multiple sclerosis. Brain 1997, 120:1085–1096
Thorpe JW, Kidd D, Moseley IF, Thompson AJ, MacManus DG, Compston DA, McDonald WI, Miller DH: Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. Brain 1996, 119:709–714
Todd, JA, Aitman TJ, Cornall RJ, Ghosh S, Hall JRS, Hearne CM, Knight AM, Love JM, McAleer MA, Prins J-B, Rodrigues N, Lathrop M, Pressey A, DeLarato NH, Peterson LB, Wicker LS. Genetic analysis of autoimmune type 1 diabetes mellitus in mice. Nature. 1991;351:542–547.
Tuohy VK, Sobel RA, Lees MB: Myelin proteolipid protein-induced experimental allergic encephalomyelitis. Variations of disease expression in different strains of mice. J Immunol 1988, 140:1868–1873
Wekerle H, Kojima K, Lannes-Vieira J, Lassmann H, Linington C: Animal models. Ann Neurol 1994, 36:S47–S53
Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol 2002; 61: 23–32.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Baker, D. (2005). Genetics of Experimental Allergic Encephalomyelitis. In: Lavi, E., Constantinescu, C.S. (eds) Experimental Models of Multiple Sclerosis. Springer, Boston, MA. https://doi.org/10.1007/0-387-25518-4_10
Download citation
DOI: https://doi.org/10.1007/0-387-25518-4_10
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25517-0
Online ISBN: 978-0-387-25518-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)